304 related articles for article (PubMed ID: 27783307)
41. Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy.
Gomaa S; Nassef M; Tabl G; Zaki S; Abdel-Ghany A
BMC Cancer; 2024 Jan; 24(1):34. PubMed ID: 38178054
[TBL] [Abstract][Full Text] [Related]
42. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
[TBL] [Abstract][Full Text] [Related]
43. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
44. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
45. GNRs@SiO₂-FA in combination with radiotherapy induces the apoptosis of HepG2 cells by modulating the expression of apoptosis-related proteins.
Gao B; Shen L; He KW; Xiao WH
Int J Mol Med; 2015 Nov; 36(5):1282-90. PubMed ID: 26648274
[TBL] [Abstract][Full Text] [Related]
46. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells.
Wright C; Iyer AKV; Kaushik V; Azad N
J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458
[TBL] [Abstract][Full Text] [Related]
47. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
[TBL] [Abstract][Full Text] [Related]
48. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.
Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC
Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051
[TBL] [Abstract][Full Text] [Related]
49. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
50. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
51. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
52. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
[TBL] [Abstract][Full Text] [Related]
53. Fabrication of multifunctional SiO2@GN-serum composites for chemo-photothermal synergistic therapy.
Liu Y; Bai J; Jia X; Jiang X; Guo Z
ACS Appl Mater Interfaces; 2015 Jan; 7(1):112-21. PubMed ID: 25474753
[TBL] [Abstract][Full Text] [Related]
54. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
55. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
[TBL] [Abstract][Full Text] [Related]
56. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
57. [Effect of AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleoside on proliferation, differentiation and apoptosis in U937 cells].
Lü C; Cao J; Meng FJ; Zeng LY; Chen C; Wu QY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):153-6. PubMed ID: 23611224
[TBL] [Abstract][Full Text] [Related]
58. Core-interlayer-shell Fe
Liu G; Ma J; Li Y; Li Q; Tan C; Song H; Cai S; Chen D; Hou Z; Chen Q; Zhu X
Int J Pharm; 2017 Apr; 521(1-2):19-32. PubMed ID: 28163230
[TBL] [Abstract][Full Text] [Related]
59. Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression.
Hasanifard L; Samadi N; Rashtchizadeh N; Dastmalchi S; Karimi P
Drug Res (Stuttg); 2018 Jan; 68(1):45-53. PubMed ID: 28950390
[TBL] [Abstract][Full Text] [Related]
60. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
